Выбор редакции
19 марта, 12:58

Фарма vs COVID-19: маски, тесты, лекарства

Пока страны по всему миру спешно закрывают свои границы, фармацевтические компании в срочном порядке ведут разработку вакцин от COVID-19. В этом материале мы постарались собрать те компании, которые производят или разрабатывают товары, пользующиеся спросом во время эпидемии и акции которых торгуются на Санкт-Петербургской бирже. Всего в обзор вошли 12 компаний из трех групп: производители медицинских масок, производители диагностических тестов и разработчики вакцин. Группа №1: медицинские маски В период распространения заболеваний, передающихся воздушно-капельным путем, спрос на медицинские маски среди населения значительно возрастает. Однако сейчас он просто зашкаливает, ведь Всемирная организация здравоохранения, а за ней и все локальные медицинские учреждения, рекомендуют носить маску в качестве профилактики и защиты от вируса COVID-19.Какие виды масок существуют?Хирургические маски – самые распространенные и популярные среди потребителей, но слабоэффективные. Из-за неплотного прилегания и низкой плотности материала, из которой они сделаны, вероятность проникновения бактерий остается довольно высокой. Однако такие маски хорошо предотвращают распространение микробов от инфицированного человека. Кроме того, есть исследования, подтвердившие, что люди, которые носили хирургические маски в одной комнате с больным членом семьи, снижали риск заражения, но только если они носили их постоянно.Хирургические маски N95 считаются самой надежной защитой от болезней. Они названы так благодаря своей способности отфильтровать 95% мелких частиц, а с ними и микробов. При правильной установке макса N95 герметично закрывает нижнюю половину лица, но чтобы дышать в такой маске, надо прилагать больше усилий. Отметим, что маски N95 предназначены для врачей, а не для массового использования и требуют специального обучения того, как правильно их надевать и носить. Существуют также маски P100, которые блокируют 99,9% частиц размером 0,3 микрона.Тканевые маски – самые опасные из всех. Если такая маска плохо промыта или недостаточно высушена, то она может наоборот создать благоприятную среду для размножения бактерий.Строительные маски для защиты от пыли считаются также малоэффективными в борьбе с  заболеваниями, так как они предназначены для блокирования попадания в нос и рот более крупных частиц, чем вирусы.В конце февраля министерство здравоохранения и социальных служб США заявило, что у него имеется в запасе 30 миллионов респираторов N95, но говорит, что ему потребуется 300 миллионов, поскольку риск коронавируса продолжает расти.На санкт-Петербургской бирже торгуются несколько крупных производителей медицинских масок:Компания Honeywell International Inc. (SPB: HON)  со штаб-квартирой в штате Калифорния, поставляет респираторы, фильтры и картриджи одноразового использования, а также предоставляет различные виды одноразовых масок N95 с клапанами и без них.В ассортименте 3M Company (SPB: MMM)  есть различные виды хирургических масок иреспираторов N95. Компания также предлагает другие хирургические принадлежности, включая простыни, антимикробные повязки и послеоперационные повязки.Еще один крупный производитель процедурных, хирургических масок и респираторов N95 — это Kimberly-Clark Corporation (SPB: KMB). Компания производит большое количество средств защиты для врачей, массового потребителя и детей. В свою очередь такие американские магазины как Walgreens (SPB: WBA), Home Depot (SPB: HD), Lowe's (SPB: LOW) сообщают о резком росте продаж масок за последние несколько недель. Группа №2: диагностические тестыВ диагностировании коронавируса ключевую роль играют диагностические тесты. Само тестирование для пациентов достаточно прост — это мазок из носа или горла, а вот процесс обнаружения вируса гораздо сложнее. Все существующие на данный момент тесты работают по принципу поиска генетического материала вируса (РНК) в клетках пациента. Чтобы обнаружить присутствие РНК в анализе, лаборатории проводят тест. Этот метод сначала преобразует любую вирусную РНК в ДНК. Затем ДНК реплицируется, пока не будет достаточно копий для обнаружения вируса при помощи ПЦР-диагностики. На получение результатов теста уходит 24-72 часа.Один из первых диагностических тестов был разработан в январе текущего года компанией  Charité, головной офис которой находится в Берлине. 250 000 тестов этой компании закупила всемирная организация здравоохранения (ВОЗ). ВОЗ уже отправила наборы для тестирования в 57 стран.Около месяца назад в Китае были разработаны пять коммерческих диагностических тестов, таким образом, Поднебесная может  проводить до 1,6 миллиона тестов в неделю. Еще один крупный производитель – это южнокорейская компания Kogenebiotech. На начало марта Южная Корея проверила 65 000 человек.Центры по контролю и профилактике заболеваний США с момента начала эпидемии до первых чисел марта провели только около 500 тестов. Как и следует ожидать, спрос на них сейчас фантастический. Производить собственные диагностические тесты Америка начала относительно недавно. С 5 марта появились тесты от компании LabCorp, с 9 марта от Quest Diagnostics Incorporated (SPB: DGX), акции которой торгуются на Санкт-Петербургской бирже. Группа №3: лекарства для лечения и профилактикиСША и тут, конечно же, форсирует события, ведь первый получивший действующую вакцину, получит наибольшую прибыль. Финансируют исследования различные источники. Это и BARDA — Управление перспективных биомедицинских исследований и разработок министерства здравоохранения и социальных служб США, NIAID — Национальный институт аллергии и инфекционных заболеваний, а также CEPI — Коалиция за инновации в обеспечении готовности к эпидемиям, фонд, который получает пожертвования от государственных, частных, благотворительных организаций и инвестирует в независимые исследовательские проекты по разработке вакцин.Давайте посмотрим, какие компании, из тех, что торгуются на Санкт-Петербургской бирже, вступили в гонку по исследованию COVID-19.Pfizer Inc. (SPB: PFE) 17 марта Pfizer объявила о сотрудничестве с немецкой компанией BioNTech в рамках разработки вакцины против COVID-19. BioNTech специализируется на разработках в области новых видов иммунотерапии. Обе компании уже не раз объявляли о совместных проектах в разработке вакцин против гриппа на основе мРНК. Согласно соглашению о намерениях компании планируют совместную разработку и реализацию вакцины, предназначенной для профилактики вирусной инфекции COVID-19. Тестирование на людях вакцины-кандидата планируется в конце апреля.  16 марта BioNTech также заключила соглашение о с Shanghai Fosun Pharmaceutical, передав Fosun права на реализацию вакцины в Китае.Regeneron Pharmaceuticals Inc. (SPB: REGN) В начале февраля Regeneron Pharmaceuticals объявила о том, что занимается разработкой лекарства для лечения COVID-19 по технологии моноклональных антител. Исследования компания проводит на специально выведенных мышах, иммунная система которых максимально приближена к человеческой путем генной инженерии. Компания сейчас находится на стадии доклинических испытаний, но рассчитывает перейти к тестированию на людях к концу августа текущего года.Moderna Inc. (SPB: MRNA) В конце января Moderna получила финансирование от CEPI на разработку вакцины против COVID-19 на основе РНК технологий. 24 февраля компания сообщила, что отправила первую партию мРНК-1273 в NIAID для клинического испытания первой фазы в США. 21 февраля NIAID объявил о наборе 45 здоровых взрослых пациентов для участия в открытом клиническом исследовании тестирования мРНК-1273 в качестве вакцины для COVID-19. Исследования первой фазы должны стартовать 19 марта и завершиться 1 июня 2021 года.Gilead Sciences Inc. (SPB: GILD) В разработке находится лекарственный препарат Remdesivir, который сейчас проходит третью фазу клинических испытаний. Gilead Sciences поистине динозавр биофармы, который в свое время  полностью изменил стандарты лечения гепатита С, а также с успехом реализует препараты от ВИЧ инфекции. Сейчас компания бросила значительные силы на разработку лекарств против COVID-19. В феврале Национальное управление лекарственных средств (NMPA) Китая одобрило испытания лекарства в Ухани. 3 мая стартовали тестрования на пациентах Remdesivir. В испытаниях участвуют 400 человек с легкой формой пневмонии  и 600 со средней. Результаты исследований ожидаются в мае 2020 года.Sanofi ADR (SPB: SNY) Начиная с 18 февраля, Sanofi совместно с BARDA готовит для тестирования против COVID-19 вакцину-кандидата, разработанную против другого коронавируса — SARS  вируса атипичной пневмонии. Французская лаборатория планирует углубить свои исследования в области передовой доклинической вакцины-кандидата, которая разрабатывалась в качестве ответа на всплеск респираторных заболеваний вызванных SARS, которые достигли пика в 2003 году. Производитель лекарств предполагает, что вакцина может защитить от Covid-19. Sanofi планирует ввести вакцину в первую фазу клинических испытаний в период с марта 2021 года по август 2021 года.AbbVie (SPB: ABBV) AbbVie одна из компаний, которые ищут коронавирусные препараты среди своих существующих лекарств. В частности китайские власти уже используют препараты AbbVie против ВИЧ для лечения пневмонии. Препарат Kaletra (также известный как Aluvia), разработанный против атипичной пневмонии SARS,  содержит противовирусные компоненты, которые блокируют репликацию вируса. Несмотря на то, что Kaletra еще не была одобрена для лечения коронавируса, она показала эффективность во многих случаях. AbbVie выделила препарат Kaletra общей стоимостью в $ 1,5 млн  для экспериментального лечения.Takeda Pharmaceutical Company Ltd. ADR (SPB: TAK) 4 марта Takedа объявила о том, что вступает в исследовательскую гонку против вируса пневмонии. Свои исследования компания планирует построить на основе плазмы крови людей, которые выздоровели или получали лечение от COVID-19. Гиппериммуноглобулины, или препараты на основе плазмы, по мнению представителей Takedа  доказали свою эффективность в лечении острых респираторных заболеваний. Кроме того, компания планирует изучить не только одобренные регулирующими органами методы лечения, но и экспериментальные.Johnson & Johnson (SPB: JNJ) 11 февраля J & J сообщил, что работает с BARDA над разработкой вакцины против COVID-19. При этом исследования финансируются совместно, а первая фаза тестирования исключительно BARDA. 13 марта J & J объявили о начале доклинических испытаний нескольких кандидатов совместно с бостонским Beth Israel Deaconess Medical Center, планируя получить вакцину-кандидата к концу месяца. При положительном исходе первая фаза клинических испытаний планируется на конец 2020 года. Кроме того, ранее J & J объявлял о сотрудничестве с BARDA в проекте, направленном на тестирование экспериментальных и одобренных противовирусных препаратов, которые могли бы быть эффективными против COVID-19. 

Выбор редакции
Выбор редакции
Выбор редакции
19 сентября 2019, 15:58

Home Depot And Lowe’s Accused Of Scanning Millions Of Customers Faces

By MassPrivateI Home improvement stores like Home Depot and Lowe’s have become partners in Big Brother’s ever expanding public surveillance program. Home Depot’s “You Can Do...

30 ноября 2018, 22:24

What Are The Biggest Data Breaches?

What Are The Biggest Data Breaches?

Выбор редакции
30 ноября 2018, 01:45

Home Depot (HD) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Home Depot (HD) closed at $175.66, marking a -1% move from the previous day.

29 ноября 2018, 18:22

‘Blue Bloods’: Where Will Jamie Reagan and Eddie Janko Have Their Wedding?

Jamie Reagan and Eddie Janko start wedding planning with the rest of the Reagan family's help on 'Blue Bloods.' Where will they have their wedding?

29 ноября 2018, 09:48

The Market Loved Powell's Speech!

The Market Loved Powell's Speech!

Выбор редакции
02 апреля 2018, 21:00

Watch Guide: Speaker Ryan Talks Tax Reform at Southwest Airlines

Coming up in a little bit, Speaker Ryan will be talking about tax reform with employees at Southwest Airlines's headquarters in Dallas, TX. The carrier is one of hundreds of companies that have announced employee bonuses since teTax Cuts and Jobs Act became law. Ryan will be joined today by House Ways and Means Committee Chairman Kevin Brady (R-TX), one of the law’s chief architects. You’ll be able to watch the employee forum at 4:30 p.m. ET/3:30 p.m. CT live on Speaker.gov. While you wait for the event to start, here are a few things to check out: This video or these clips from Speaker Ryan’s recent visit to Home Depot, where he talked about the benefits tax reform is delivering directly to American workers, from bigger paychecks and bonuses to an expanded child tax credit. This story of how a Maryland manufacturer that Speaker Ryan visited in the run-up to tax reform recently announced bonuses for its employees. Based in Kent County, this is a company with a 102-year history and more than 1,000 employees across 14 states. This map showing that tax reform has helped lower utility prices for customers in 41 states (and counting.) OK, that was technically four things, but tax reform has brought a lot of good news for America’s workers, and optimism abounds. Just a couple of items from last week: “Consumer sentiment in March reached the highest level since 2004. . . The advance in confidence underscores buoyant consumer sentiment following tax cuts and one-time bonuses that boosted many Americans’ take-home pay.” (Bloomberg) “The rate of layoffs in the U.S. fell again in late March and dropped to the lowest level since 1973. . . . The labor market is so strong that it’s even drawing back in people who’ve been out of the workforce for years. And it doesn’t show any sign of letting up.” (MarketWatch) So be sure to tune in to speaker.gov/live at 4:30 p.m. ET/3:30 p.m. CT as Speaker Ryan keeps this conversation going and fields questions from Southwest employees.

02 апреля 2018, 15:46

Wall Street. Акции на премаркете

(компания / тикер / цена / изменение ($/%) / проторгованый объем) ALCOA INC. AA 44.55 -0.41(-0.91%) 745 Amazon.com Inc., NASDAQ AMZN 1,424.50 -22.84(-1.58%) 54338 Apple Inc. AAPL 167.57 -0.21(-0.13%) 135173 Barrick Gold Corporation, NYSE ABX 12.6 0.15(1.20%) 3500 Boeing Co BA 324 -3.88(-1.18%) 12073 Caterpillar Inc CAT 145.4 -1.98(-1.34%) 1218 Chevron Corp CVX 114.45 0.41(0.36%) 777 Cisco Systems Inc CSCO 42.55 -0.34(-0.79%) 12302 Citigroup Inc., NYSE C 68.1 0.60(0.89%) 138659 Deere & Company, NYSE DE 155 -0.32(-0.21%) 674 Exxon Mobil Corp XOM 74.4 -0.21(-0.28%) 2628 Facebook, Inc. FB 158.62 -1.17(-0.73%) 160454 FedEx Corporation, NYSE FDX 240 -0.11(-0.05%) 346 Ford Motor Co. F 11.06 -0.02(-0.18%) 9998 Freeport-McMoRan Copper & Gold Inc., NYSE FCX 17.72 0.15(0.85%) 23101 General Electric Co GE 13.41 -0.07(-0.51%) 42047 General Motors Company, NYSE GM 36 -0.34(-0.94%) 1117 Goldman Sachs GS 249.97 -1.89(-0.75%) 2265 Google Inc. GOOG 1,028.00 -3.79(-0.37%) 6316 Hewlett-Packard Co. HPQ 22 0.08(0.37%) 201 Home Depot Inc HD 177.7 -0.54(-0.30%) 624 Intel Corp INTC 51.64 -0.44(-0.84%) 57971 International Business Machines Co... IBM 151.74 -1.69(-1.10%) 231 Johnson & Johnson JNJ 129.57 1.42(1.11%) 572 JPMorgan Chase and Co JPM 109.7 -0.27(-0.25%) 10059 McDonald's Corp MCD 157.7 1.32(0.84%) 7185 Merck & Co Inc MRK 54.14 -0.33(-0.61%) 996 Microsoft Corp MSFT

02 апреля 2018, 11:13

Хакеры украли данные 5 млн банковских карт

Хакеры из группировки Fin7, также известной под названием JokerStash, выкрали данные кредитных карт более чем 5 млн американцев.

02 апреля 2018, 11:13

Хакеры украли данные 5 млн банковских карт

Хакеры из группировки Fin7, также известной под названием JokerStash, выкрали данные кредитных карт более чем пяти миллионов американцев.

01 апреля 2018, 04:42

What If All The Cheap Stuff Goes Away?

Authored by Charles Hugh Smith via OfTwoMinds blog, Nothing stays the same in dynamic systems, and it's inevitable that the current glut of low costs / cheap stuff will give way to scarcities that cannot be filled at current low prices. One of the books I just finished reading is The Fate of Rome: Climate, Disease, and the End of an Empire. The thesis of the book is fascinating to those of us interested in the rise and fall of empires: Rome expanded for many reasons, but one that is overlooked was the good fortune of an era of moderate weather from around 200 BC to 150 AD: rain was relatively plentiful/ regular and temperatures were relatively warm. Then one of Earth's numerous periods of cooling--a mini ice age--replaced the moderate weather, pressuring agricultural production. Roman technology and security greatly expanded trade, opening routes to China, India and Africa that supplied much of Roman Europe with luxury goods. The Mediterranean acted as a cost-effective inland sea for transporting enormous quantities of grain, wine, etc. around the empire. These trade routes acted as vectors for diseases from afar that swept through the Roman world, decimating the empire's hundreds of densely populated cities whose residents had little resistance to the unfamiliar microbes. Rome collapsed not just from civil strife and mismanagement, but from environmental and infectious disease pressures that did not exist in its heyday. Colder, drier weather stresses the populace by reducing their food intake, which leaves them more vulnerable to infectious diseases. This dynamic was also present in the 15th century during another mini ice age, when the bubonic plague (Black Death) killed approximately 40% of Europe's population. Which brings us to the present: global weather has been conducive to record harvests of grains and other foodstuffs, and I wonder what will happen when this run of good fortune ends, something history tells us is inevitable. Despite the slow erosion of inflation, food is remarkably cheap in the developed world. What happens should immoderate weather strike major grain-growing regions of the world? Then there's infectious diseases.  Global air travel and trade has expanded the spectrum of disease vectors to levels that give experts pause.  The potential for an infectious disease that can't be mitigated to spread globally is another seriously under-appreciated threat to trade, tourism and cheap stuff in general. There are other factors that could spell the end of cheap stuff, not just food but manufactured goods: 1. Fossil fuels could become much more costly. While I consider it highly likely that the price of oil in US dollars will fall to $40/barrel or lower in a global recession due to a sharp drop in demand (what I've long termed the head-fake), longer term, it's inevitable that the cheap-to-access fossil fuels (other than coal) will become depleted and the cost of accessing, processing and transporting what's left will rise. Since fossil fuels remain the backbone of industrial societies everywhere (yes, including Germany), a steady increase in fuel costs will push the cost of everything that uses energy (i.e. everything) higher. 2. Trade restrictions/conflicts. Globalization and populism both target "unfair trade practices" in which "unfair" is in the eye of the beholder: imports hurt the domestic economy everywhere, and exports help the domestic economy everywhere. If trade is restricted for whatever reason, the costs of commoditized goods will likely increase, possibly by a lot. 3. Global wages are rising. You've probably seen signs at Home Depot and fast-food chain outlets announcing "we're hiring": even though 100 million working-age people are "not in the work force" in the U.S., many of these individuals lack the skills and/or willingness to take jobs in the modern economy, which demand a lot of workers even in so-called low-skill fields such as fast food. To work in fast food, individuals must be able to handle high pressure and a fast pace; it's not an easy job by any means. Many employers are reporting that they can't find enough qualified candidates who pass drug tests, yet another fallout of the opioid epidemic. Many people are saddled with felony convictions for nonviolent drug offenses, rendering them ineligible for most corporate or government employment. Immigration restrictions and minimum wage laws will add to the rising cost of labor. Globally, the baby Boom generation is retiring, leaving worker shortages on the horizon even in China. (Note that workers tend to retire much earlier in Asia and Europe than in the U.S.: 60 or 62 is typically the mandatory retirement age in much of the global economy.) As Immanuel Wallerstein has observed (I've written about his work many times), there are systemic, secular pressures to raise wages and benefits everywhere: costs are rising, and people expect more government services such as education and income security, and as taxes increase, wages must rise to maintain the net earnings (purchasing power) of the workers. We in North America have become accustomed to cheap stuff; we consider it our birthright: cheap fuels, cheap manufactured goods, cheap food and cheap labor. Without even being aware of it, we feel entitled to "low prices always." We may feel fuel, food and consumer goods are expensive now, but we are comparing prices to an extended period of extraordinarily low costs. Prices for energy could easily rise 50%, impacting the cost of everything; should harvests be crippled by bad weather, the cost of grains could easily double or triple from their current historic lows. Should trade be restricted and wages rise virtually everywhere, manufactured consumer goods could go up in price even as robots replace human labor: energy and raw materials will still be costly inputs even if all human labor is eliminated. Add in some stiff tariffs for unfair trade practices, and all the robots in the world won't keep prices down. Nothing stays the same in dynamic systems, and it's inevitable that the current glut of low costs / cheap stuff will give way to scarcities that cannot be filled at current low prices. Cheap stuff will go away, and everything will cost more. It seems highly likely that the next decade will not be like the last 10 years of abundance and cheap stuff. Courtesy of Incrementum AG, here is a chart of the commodity/S&P 500 ratio. Commodities are at historic lows in relation to stock market valuations. Stocks can decline, or commodities can rise, or both can occur in tandem. If history is any guide, this ratio will reverse and reach a peak within the next decade. *  *  * My new book Money and Work Unchained is $9.95 for the Kindle ebook and $20 for the print edition. Read the first section for free in PDF format. If you found value in this content, please join me in seeking solutions by becoming a $1/month patron of my work via patreon.com.

30 марта 2018, 23:20

The Elite Eight: March in Photos

Now we know why they call it March Madness. This month, Speaker Ryan met with more than a dozen foreign dignitaries (including Israeli Prime Minister Benjamin Netanyahu), signed several important pieces of legislation, gave an official address to the Czech Parliament in Prague, and much more. Here are eight photos that show some of our favorite moments from the month of March: 1. The Battle of Ideas – During an interview for Ben Shapiro's podcast, Speaker Ryan and the host engage in a lively discussion about political philosophy, natural rights, and the battle of ideas. 2. The Spring Cohort – Speaker Ryan sits down with his offices’ spring interns, answering their questions and offering advice as they start their careers. 3. The Home Depot Visit – While visiting Home Depot in Atlanta, Georgia, to talk about the benefits of tax reform, Speaker Ryan cracks a joke during a drilling demo. 4. The Friends of Ireland Luncheon – Speaker Ryan and the Taoiseach of Ireland, Leo Varadkar, welcome President Trump and Vice President Pence to the Capitol for the annual Friends of Ireland luncheon. 5. The School Safety Discussion – Speaker Ryan meets with Rep. Ted Deutch (D-FL) and Max and Ryan Schachter—who lost their son and brother, Alex, in the tragic shooting in Parkland—to discuss what more could be done to ensure our country’s schools are safe. Much-needed school safety improvements were signed into law by the president this month. 6. The Fight to #EndTrafficking – Alongside Sen. Rob Portman (R-OH) and Reps. Ann Wagner (R-MO) and Mimi Walters (R-CA), Speaker Ryan signs critical legislation that cracks down on bad-actor websites that facilitate human trafficking. 7. The Czech Address – During a visit to the Czech Republic to address its parliament, Speaker Ryan had the chance to thank U.S. Embassy Prague staff and their families for the sacrifices they make to represent our country. 8. The Prime Minister Meeting – Speaker Ryan welcomes Israeli Prime Minister Benjamin Netanyahu to the Capitol, prior to a meeting with members of House leadership. As for Speaker Ryan’s bracket, there’s always next year.

30 марта 2018, 16:39

US GDP Revised Up: ETFs to Buy

U.S. economic growth slowdown lower than earlier expected in the fourth quarter, as rising consumer spending offset drags on GDP.

Выбор редакции
29 марта 2018, 16:49

The Power of Tax Reform

This, is the Home Depot. They employ hundreds of thousands of Americans. And their hourly associates just got a bonus because of tax reform. It’s the one thing that changes everything. Finally: Less talking. More doing. Now, let’s keep the momentum going. More jobs. Bigger paychecks. That’s the power of tax reform.

29 марта 2018, 15:43

Wall Street. Акции на премаркете

(компания / тикер / цена / изменение ($/%) / проторгованый объем) ALCOA INC. AA 44.6 0.18(0.41%) 1000 ALTRIA GROUP INC. MO 62.87 0.42(0.67%) 774 Amazon.com Inc., NASDAQ AMZN 1,429.00 -2.42(-0.17%) 169891 American Express Co AXP 92.88 0.67(0.73%) 225 Apple Inc. AAPL 167.95 1.47(0.88%) 158462 AT&T Inc T 35.71 0.15(0.42%) 2098 Boeing Co BA 322.95 2.93(0.92%) 21591 Caterpillar Inc CAT 146.25 1.09(0.75%) 1697 Chevron Corp CVX 112.37 0.27(0.24%) 323 Cisco Systems Inc CSCO 41.99 0.33(0.79%) 4462 Citigroup Inc., NYSE C 68.5 0.24(0.35%) 1478 Exxon Mobil Corp XOM 73.03 0.22(0.30%) 7948 Facebook, Inc. FB 154.77 1.74(1.14%) 419979 Ford Motor Co. F 10.93 0.07(0.64%) 9200 Freeport-McMoRan Copper & Gold Inc., NYSE FCX 16.95 0.20(1.19%) 12050 General Electric Co GE 13.74 0.06(0.44%) 170167 General Motors Company, NYSE GM 35.55 0.08(0.23%) 2337 Goldman Sachs GS 250.7 1.33(0.53%) 1539 Google Inc. GOOG 1,010.12 5.56(0.55%) 7084 Hewlett-Packard Co. HPQ 21.82 0.13(0.60%) 201 Home Depot Inc HD 176.1 1.34(0.77%) 661 HONEYWELL INTERNATIONAL INC. HON 143.51 0.25(0.17%) 671 Intel Corp INTC 49.95 0.35(0.71%) 18107 International Business Machines Co... IBM 153 0.48(0.31%) 522 Johnson & Johnson JNJ 128.1 0.65(0.51%) 314 JPMorgan Chase and Co JPM 108.74 0.74(0.69%) 3546 McDonald's Corp MCD 159.5 1.09(0.69%) 459 Merck & Co Inc MRK

Выбор редакции
29 марта 2018, 12:05

Facebook’s silver lining: Data furors fade

First comes the news of yet another improper leak of personal data. Then the outrage and investigations in Washington, the calls for a chastened CEO to testify in front of Congress, the cries for tough news laws and regulations to protect people’s privacy. Then, typically, nothing much happens.The Facebook privacy scandal could turn out differently. But that would make it the exception in a long string of U.S. data-privacy furors, which have come and gone with no serious laws, rules or other major repercussions for companies like Equifax, Yahoo, Uber or Home Depot — even those whose leaks were arguably worse than Facebook’s.Lax security at Equifax, for example, allowed hackers to steal highly personal and financial data on as many as 148 million Americans — exposing them to the risk of identity theft and ruined credit. But nearly seven months after that news broke, Congress has largely dropped the issue, while state and federal regulators are investigating.Much the same is true for Yahoo, which admitted last fall to two mammoth breaches that exposed the data on all 3 billion of its users, feeding the black market for identity thieves and allegedly giving Russian intelligence officers access to high-value email accounts. While Yahoo took a financial hit — Verizon shaved $350 million from its offer to buy the company — lawmakers weren’t able to move any serious responses.“My hope is that [this time] is different, but my fear is that a lot of Americans throw up their hands and say, ‘What can I do?’” said Justin Hendrix, who heads the NYC Media Lab and is helping lead a tech and media initiative called Regulate Social Media. “You’ve got all this momentum, but even if the ball’s really rolling, it’s not clear what direction it’s going to roll,” added Jake Laperruque, a digital privacy specialist with the Project on Government Oversight.Still, advocates retain a degree of optimism that Cambridge Analytica’s repurposing of data on 50 million Facebook users during the 2016 election might eventually lead to regulatory changes — even if it doesn’t occur in the coming months. They say this latest digital misconduct gets to the visceral issue of Americans’ ability to conduct fair elections, making it different than the more common data breaches that have become a regular occurrence. “It seems like more than ever before if we don’t act, [lawmakers] are actually abdicating their responsibility to people across the country,” said Amie Stepanovich, U.S. policy manager for the digital rights group Access Now. Doing nothing, Hendrix added, is “not an option if you prefer democracy.” Still, the track record of other headline-grabbing data scandals offers reason for skepticism that Washington is about to break up Facebook, hit it with multitrillion-dollar fines, regulate it like a utility or impose the other draconian penalties people have floated.Here’s a look at how those other data furors have played out:YAHOOWhen: Occurred in 2013 and 2014, discovered in 2017How many people affected: 3 billionWhy it mattered: The twin breaches set records for the number of people compromised in a single digital intrusion. The first one, which alone hit 3 billion, will probably never be matched unless someone breaches every single user of a company like Google. (The second Yahoo breach exposed 500 million Yahoo users.)Prosecutors, who secured indictments of four men for the smaller hack, said Russian intelligence agents conspired with notorious criminal hackers to steal the data, then used it to build dossiers on journalists, dissidents and U.S. officials. Meanwhile, the criminals leveraged it to steal identities and launch email spam schemes.Consequences: Congress largely let the Yahoo incident slide with little more than a public chastising of former CEO Marissa Mayer, whom the Senate Commerce Committee subpoenaed to testify last November. Committee Chairman John Thune (R-S.D.) said Mayer’s testimony would be “important in shaping our future reactions,” but his committee has yet to move any related legislation. EQUIFAXWhen: Occurred and discovered in 2017How many people affected: 148 million, potentially half the adult U.S. populationWhy it mattered: This may have been the most damaging breach of all time, especially because the information that was compromised — such as Social Security numbers — is considered the crown jewels for identity thieves. (Democratic Sen. Elizabeth Warren of Massachusetts has alleged that it also included passport numbers, which the company denies.)The company compounded matters with a slow, confusing response that included an apparent attempt to limit customers’ rights to sue, as well as suspicious stock sales that led to recent insider-trading charges against a former executive who dumped nearly $1 million in Equifax shares before the breach was announced.Consequences: Congress proposed myriad changes to the legal requirements for companies to respond to data leaks and protect Americans’ sensitive information, and Democratic bills sought to tighten oversight of credit reporting companies more specifically.But momentum stalled within months. A working group featuring senior lawmakers from both parties was effectively put on hold, falling victim to years-old battles between industries such as banking, retailing and telecommunications over whom any legislation would cover and what the specific security and privacy requirements should be.Meanwhile, the Senate passed a sweeping banking bill this month that would reward Equifax and other credit monitoring companies by protecting them from some consumer lawsuits and letting them expand into the mortgage business.However, regulators have descended on Equifax in the wake of the incident. Both the Federal Trade Commission and a number of states are examining whether there was any malfeasance in the way the company handled the breach.UBERWhen: Occurred and discovered in 2016, covered up until 2017How many people affected: 57 millionWhy it mattered: This breach added a new element to the discussion — the cover-up. The ride-hailing giant revealed last November that it had conspired for more than a year to keep the leak secret by paying the hackers $100,000 to destroy the data. That way, the company hoped to keep the data off the black markets, where a researcher might discover it and alert the public.Uber’s actions may have violated state laws requiring companies to alert victims, authorities and regulators about the breach.Consequences: Numerous states are investigating the matter, and the FTC — which had previously penalized Uber over privacy issues — has said it is “closely evaluating the serious issues” raised by the incident.On Capitol Hill, Uber got roped into the Equifax fallout. Lawmakers also pushed proposals to address the specifics of the Uber breach, including a bill co-sponsored by three Democratic senators that would let prosecutors seek jail time for individuals who knowingly cover up a data breach. But that bill has shown no signs of moving.TARGET When: Occurred and discovered in 2013How many people affected: 40 million Why it mattered: This was the breach that started it all. While Target was far from the first company to experience a digital intrusion, the infiltration over the 2013 holiday season infiltration brought the issue into mainstream conversation. The exposure of 40 million customers’ payment card data was a gobsmacking figure at the time and made those victims easy targets for fraud.Consequences: A Target executive appeared on Capitol Hill within weeks, and lawmakers re-upped dormant proposals to require timely breach notification for victims. Lawmakers on both sides of the aisle expressed an interest in such an idea. “This might provide the chance to take action quickly,” said Iowa Sen. Chuck Grassley, then the top Republican on the Judiciary Committee.Some Democrats also pushed for a law that would instruct the FTC to write nationwide digital security standards for companies handling sensitive data.Nothing ultimately happened in Congress. However, CEO Gregg Steinhafel resigned several months later, in part due to the breach. Target agreed in 2015 to pay affected banks $39.4 million to cover their expenses and struck a deal with Visa to give $67 million to credit card companies’ victimized customers. A class action settlement is still pending.In total, Target has said it spent over $200 million recovering from the breach.HOME DEPOTWhen: Occurred and discovered in 2014How many people affected: 56 millionWhy it mattered: This theft of credit card data showed the public that Target was far from unique, and set the record at the time for the largest retail card breach ever. Ensuing news reports revealed that the home improvement giant had ignored years of warnings from its own computer experts that its systems were vulnerable.Consequences: Capitol Hill went through the same motions: outrage, a demand for testimony and a vow to change things.“I do sincerely believe that is an achievable goal,” said Rep. Michael Burgess (R-Texas), then the chairman of the House Subcommittee on Commerce, Manufacturing and Trade, at a January 2015 hearing. The hearing followed both the Home Depot breach and a leak at banking giant JPMorgan Chase that compromised 83 million accounts. But nothing much happened.The company’s business didn’t even suffer significantly, with sales remaining in line with expectations the month the breach was announced. Home Depot also didn’t change its expectations for sales growth for fiscal 2014. And despite a brief dip in stock price after the breach was revealed, Home Depot’s stock price is nearly double today what it was in late 2014.Like Target, the company has had to settle a variety of lawsuits, agreeing in 2016 to pay at least $19.5 million to victims and doling out $25 million to banks last year. In total, the company says the breach has cost it at least $179 million. U.S. OFFICE OF PERSONNEL MANAGEMENTWhen: Occurred in 2014, discovered in 2015How many people affected: 22 millionWhy it mattered: This breach, blamed on Chinese hackers, exposed some of the government’s most sensitive documents — the detailed questionnaires used to process security clearances for more than 20 million current and former federal employees and applicants. It also included personnel files on every federal worker and was a huge espionage victory for Beijing.Security clearance applications are exhaustive, including 127 pages of details on people’s most closely held secrets, such as affairs, drug and alcohol abuse or bankruptcies. Intelligence professionals say they are a treasure trove for blackmail and can be used to identify undercover American agents, especially when cross-referenced with data like airline travel logs, which Chinese hackers are also suspected of stealing.Consequences: The OPM breach could be considered the one digital privacy scare that led to serious ramifications and concrete action. Within weeks, then-OPM Director Katherine Archuleta stepped down after running a gantlet of Capitol Hill hearings where lawmakers admonished her handling of the agency’s digital security practices. Months later, the agency’s chief information officer resigned under pressure from Congress. And the incident led to a broad overhaul of the government's security clearance process, which put the Defense Department in charge of protecting the background check forms.Meanwhile, lawmakers revived a long-stalled proposal to offer incentives for companies to share more data on hacking threats with the government. By December 2015, just six months after OPM revealed the breach, the legislation became law. It was the first major cybersecurity bill Congress had approved in years — and, so far, it’s the last one.

28 марта 2018, 16:02

Wall Street. Акции на премаркете

(компания / тикер / цена / изменение ($/%) / проторгованый объем) ALCOA INC. AA 44.93 0.03(0.07%) 3475 ALTRIA GROUP INC. MO 61.25 0.53(0.87%) 2290 Amazon.com Inc., NASDAQ AMZN 1,463.00 -34.05(-2.27%) 207417 American Express Co AXP 91.21 -0.21(-0.23%) 616 Apple Inc. AAPL 167.14 -1.20(-0.71%) 503121 AT&T Inc T 35.08 0.18(0.52%) 24516 Barrick Gold Corporation, NYSE ABX 12.43 -0.13(-1.04%) 2284 Boeing Co BA 321.7 0.58(0.18%) 15747 Caterpillar Inc CAT 147 0.01(0.01%) 2023 Chevron Corp CVX 114.8 0.14(0.12%) 900 Cisco Systems Inc CSCO 42.52 -0.16(-0.37%) 70972 Citigroup Inc., NYSE C 68.14 -0.14(-0.21%) 22881 Deere & Company, NYSE DE 152 0.44(0.29%) 400 Exxon Mobil Corp XOM 73.61 -0.09(-0.12%) 4632 Facebook, Inc. FB 152.21 -0.01(-0.01%) 1051973 FedEx Corporation, NYSE FDX 233.75 -0.89(-0.38%) 1450 Ford Motor Co. F 10.82 -0.01(-0.09%) 18571 Freeport-McMoRan Copper & Gold Inc., NYSE FCX 17.15 -0.09(-0.52%) 14134 General Electric Co GE 13.54 0.10(0.74%) 483777 General Motors Company, NYSE GM 34.83 -0.04(-0.11%) 17306 Goldman Sachs GS 248 0.74(0.30%) 8548 Google Inc. GOOG 1,000.00 -5.10(-0.51%) 18452 Home Depot Inc HD 175.9 1.22(0.70%) 3362 HONEYWELL INTERNATIONAL INC. HON 146.4 2.06(1.43%) 555 Intel Corp INTC 50.65 -0.54(-1.05%) 106926 International Business Machines Co... IBM 151.85 -0.06(-0.04%) 3863 JPMorgan Chase and Co JPM 108.35 0.18(0.17%) 13915 McDonald's Corp MCD

28 февраля 2014, 14:27

16 миллиардеров, которые начали с нуля

Миллиардеров, которые самостоятельно добились экстраординарного успеха и отлично знают, что такое быть очень бедным, достаточно много. Об этих людях часто говорят - "из грязи в князи".